Tel: +86 (0)571 8102-5280
Email: sales@molcore.com
语言 :
English
中文版
日本語
Search
主页
关于我们
技术服务
定制合成
工艺开发
IP与质控
CRO&CDMO
研发和工厂
研发中心
合作工厂
产品目录
联系我们
Cas号索引 2
主页
网站地图
Cas号索引 2
最近搜索的关键词
90558-96-6
,
88131-66-2
,
131061-12-6
,
1007463-50-4
,
300851-88-1
,
1212132-25-6
,
1343343-57-6
,
3608-57-9
,
1106953-35-8
,
42065-78-1
,
1820613-23-7
,
869299-70-7
,
5743-49-7
,
85096-04-4
,
61477-96-1
,
6638-64-8
,
15205-62-6
,
1006488-79-4
,
1261893-64-4
,
1368589-20-1
,
1434128-54-7
,
182182-26-9
,
124941-87-3
,
10490-22-9
,
1137451-25-2
,
1713265-25-8
,
1807039-47-9
,
113730-55-5
,
1250782-97-8
,
23827-91-0
,
179411-83-7
,
301222-60-6
,
1353946-80-1
,
107-07-3
,
26580-58-5
,
34490-39-6
,
1804245-66-6
,
1261534-88-6
,
2183447-03-0
,
118373-61-8
,
1023559-02-5
,
1217644-25-1
,
1023540-34-2
,
1248989-63-0
,
1250346-92-9
,
728919-15-1
,
1804155-11-0
,
91-20-3
,
276694-19-0
,
23448-86-4
,
40508-01-8
,
675844-41-4
,
451485-72-6
,
478258-24-1
,
1111115-78-6
,
16387-61-4
,
98826-77-8
,
99196-57-3
,
2231674-12-5
,
478065-01-9
产品名称网站地图
Cas号索引
1
2
3
4
5
6
7
8
9
产品名字索引
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Cas号索引 2
产品编号
化学名称
分子式
MCW84469
223923-86-2 | β-L-threo-Pentofuranuronic acid, 1-[2-(acetylamino)-1,6-dihydro-6-oxo-9H-purin-9-yl]-1,2-dideoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-4-C-(hydroxymethyl)-, methyl ester (9CI, ACI)
MC284P68
223923-88-4 | β-L-threo-Pentofuranuronic acid, 1-[6-(benzoylamino)-9H-purin-9-yl]-1,2-dideoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-4-C-(hydroxymethyl)-, methyl ester (9CI, ACI)
MC2Z4467
253661-90-4 | β-L-Thymidine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-P-(2-cyanoethyl)thymidylyl-(3′→5′)-, 3′-benzoate (9CI)
MC28U466
276678-99-0 | β-L-lyxo-Heptofuranuronic acid, 1,2,3,6-tetradeoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-[[(phenylmethoxy)carbonyl]amino]-, ethyl ester (9CI)
C22H27N3O8
MCP84465
276679-01-7 | β-L-lyxo-Heptofuranuronic acid, 5-O-[bis(4-methoxyphenyl)phenylmethyl]-1,2,3,6-tetradeoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-[[(phenylmethoxy)carbonyl]amino]-, ethyl ester (9CI)
C43H45N3O10
MC2H4422
208175-19-3 | β-L-threo-Pentofuranuronic acid, 1-[4-(acetylamino)-2-oxo-1(2H)-pyrimidinyl]-1,2-dideoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-4-C-[(phenylmethoxy)methyl]-, methyl ester (9CI, ACI)
MC28P421
208175-21-7 | β-L-threo-Pentofuranuronic acid, 1-[2-(acetylamino)-1,6-dihydro-6-oxo-9H-purin-9-yl]-1,2-dideoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-4-C-[(phenylmethoxy)methyl]-, methyl ester (9CI, ACI)
MCM84420
208175-23-9 | β-L-threo-Pentofuranuronic acid, 1-[6-(benzoylamino)-9H-purin-9-yl]-1,2-dideoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-4-C-[(phenylmethoxy)methyl]-, methyl ester (9CI, ACI)
MC28A412
208175-17-1 | β-L-threo-Pentofuranuronic acid, 1,2-dideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-[(1,1-dimethylethyl)dimethylsilyl]-4-C-[(phenylmethoxy)methyl]-, methyl ester (9CI, ACI)
MC28N411
241810-72-0 | β-L-Uridine, 2′-deoxy-5-fluoro-α-L-uridylyl-(3′→5′)-2′-deoxy-5-fluoro-, 3′-acetate (9CI)
MC28W410
241810-77-5 | β-L-Cytidine, 2′-deoxy-5-fluorouridylyl-(3′→5′)-2′-deoxy-, 3′-acetate (9CI)
MC2S4408
235741-97-6 | β-L-Uridine, 2′-deoxy-5-fluoro-P-methyl-β-L-uridylyl-(3′→5′)-2′-deoxy-5-fluoro-, 3′-acetate (9CI)
MCM84400
284037-02-1 | β-Neuraminic acid, N-(trifluoroacetyl)-, methyl ester, 4,7,8,9-tetraacetate 2-(hydrogen N-acetyl-2′,3′-di-O-acetyl-5′-cytidylate) (9CI)
MC28M399
284037-04-3 | β-Neuraminic acid, N-(1-oxopentyl)-, methyl ester, 4,7,8,9-tetraacetate 2-(hydrogen N-acetyl-2′,3′-di-O-acetyl-5′-cytidylate) (9CI)
MC284F98
284037-08-7 | β-Neuraminic acid, N-(ethoxycarbonyl)-, methyl ester, 4,7,8,9-tetraacetate 2-(hydrogen N-acetyl-2′,3′-di-O-acetyl-5′-cytidylate) (9CI)
MC28S377
220765-73-1 | β-Neuraminic acid, N-[(phenylmethoxy)carbonyl]-, methyl ester, 4,7,8,9-tetraacetate 2-(2-propenyl N-acetyl-2′,3′-di-O-acetyl-5′-cytidylate) (9CI)
MC284W76
239137-83-8 | β-Neuraminic acid, N-[[(2-hydroxy-4-methylbenzoyl)amino]acetyl]-, 2-(hydrogen 5′-cytidylate) (9CI)
MC284R75
245039-59-2 | β-Neuraminic acid, N-[[2-(9-oxo-10(9H)-acridinyl)ethoxy]acetyl]-, 2-(hydrogen 5′-cytidylate) (9CI)
MC28P374
284037-06-5 | β-Neuraminic acid, N-[[(trifluoroacetyl)amino]acetyl]-, methyl ester, 4,7,8,9-tetraacetate 2-(hydrogen N-acetyl-2′,3′-di-O-acetyl-5′-cytidylate) (9CI)
MC2F4352
245039-53-6 | β-Neuraminic acid, N-[(2-propenyloxy)carbonyl]-, 2-(hydrogen 5′-cytidylate) (9CI)
MC2S4351
245039-54-7 | β-Neuraminic acid, N-(1-oxo-2-propenyl)-, 2-(hydrogen 5′-cytidylate) (9CI)
MC284C11
2225125-16-4 | β-Neuraminic acid, N-(1-oxo-4-pentyn-1-yl)-, 2-(hydrogen 5′-cytidylate) (ACI)
MC2P4299
284037-35-0 | β-Neuraminic acid, N-acetyl-8-O-methyl-, methyl ester, 4,7,9-triacetate 2-(hydrogen N-acetyl-2′,3′-di-O-acetyl-5′-cytidylate) (9CI)
MCM84298
284037-37-2 | β-Neuraminic acid, N-acetyl-, methyl ester, 4,7,8-triacetate 9-[bis(phenylmethyl) phosphate] 2-(hydrogen N-acetyl-2′,3′-di-O-acetyl-5′-cytidylate) (9CI)
MC2P4267
202644-71-1 | β-Neuraminic acid, N-acetyl-2-(N-acetyl-2′,3′-di-O-acetyl-P-methyl-5′-cytidylyl)-2-deoxy-, methyl ester, 4,7,8,9-tetraacetate (9CI)
MC284B66
220080-50-2 | β-Neuraminic acid, N-acetyl-9-[(4-carboxy-1-oxobutyl)amino]-9-deoxy-, 2-(hydrogen 5′-cytidylate) (9CI)
MC284D34
2259843-44-0 | 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-spiro[9H-fluorene-9,9′-[9H]xanthene]-2-carbonitrile
C32H26BNO3
MC284P99
2529638-38-6 | β-Neuraminic acid, N-acetyl-, 4-acetate 2-(hydrogen 5′-cytidylate) (ACI)
MCM84191
24806-85-7 | Δ2-1,2,4-Triazolin-5-one, 3-methoxy-4-methyl-1-β-D-ribofuranosyl-, 2′,3′,5′-tribenzoate (8CI)
MC2N4190
24807-01-0 | Δ2-1,2,4-Triazolin-5-one, 3-amino-1-β-D-ribofuranosyl- (8CI)
Prev
5
6
7
8
9
10
11
12
13
Next
© Copyright 2015-2025 杭州摩库生物医药科技有限公司 版权所有